1/52
Looks like no tags are added yet.
4 peptides in glucose homeostasis
GLP-1(late intest), GIP (early intes), Glucagon (alpha panc), Amylin (beta panc)
Peptide advantages
Strong effect, specific, controllable tox profile, easy to make
Peptide disadvantages
only injectable, degrade quickly
metabolic contract
organism gives cells glucose, prevents going rogue and making toxic stuff
why glucose ideal
stable, holds lots of energy, can be stored as glycogen
too much glucose
in cells, oxidative stress, in blood advanced glycation end products, a1c
things peptide hormones regulate
gluc homeostasis, energy intake, energy storage
ghrelin -release gh
needs acylation via GOAT.
ghrelin therapeutic use
agonist for cachexia, no antagonists
leptin-protein not a peptide
found in white fat, signals stop in eating
Leptin resistance
Found in obesity. No current leptin treatments besides replacement
amylin roles
slow stomach empty, glycemic control, satiety, supress glucagon
Fibril
rod prot ag/amyloid made from amylin due to beta sheet interactions
Pramilitide/Symlim
synth amylin altered to fix b structure, longer half life, for type 1 +2
Incretin effect
beta cells have glp/gip receptors, release more insulin when food eaten
recomb advantage (vector)
cheap, linear scaling, accurate, no waste
recomb disad
only 20 natural, ptm, tox/virus contam, no direct chem mods
SPPS advantage
any AA, easy to plan, no tox, no PTM
SPPS disadvantage
expensive and wasteful, scales poorly, large pep difficult, mistakes hard to fix
SPPS steps
Anchor, deprotect, wash, peptide couple, wash, repeat 2-5
GIP discovery (thought to loewr stom acid)
Through incretin effect with insulin released tracked via ria
Insulin secretion due to incretin
50-70%
GLP discovery
Through Glucagon gene sequencing
GLP-1 processing
first 6aa cleaved, last amidated
Gluc gene peptidases
PC2 in pancreas for gluc express, pcp1/3 in intestine for glp-1
Enteroendocrine cells
In intestines, take food and release hormones
K cells (duo + jeju)
associated with GIP. sense Gluc + FA, starts energy storage
L cells (ileum + colon)
associated with GLP-1, sense gluc, satiety
Dpp4
cuts incretins after ala
Exenatide mods
replace ala with glyc, cterm fold for 2nd structure
Exenatide bads
mid half life (2.4 hr) due to renal clearance, allergy
Liraglutide mods
Replace arg w/ lys (selectivity), bind lipid tail to remaining arg
LIra benefits
bind to albumin to prevent degrade, self make heptamers for depot
trulicity mods (approved for cv)
attach glp-1 to fc, large size resist renal clear and dpp4 cleave, replace ala
ozempic mods
replace ala with aib, replace arg with lys, add lipid tail, 165hr
sema side effects
muscles loss, nv, anhedonia
503B
Federal run pharmacies that can make shortage drugs (Sema off list in 2025)
503A
State pharmacies that can make specific scripts (lower dose)
oral sema
SNAC 40:1 ratio monolith tab
SNAC roles
Buffer peptic acid (inactivate peptidase), disrupt cell memb, prevent sema aggregates via lipid tail
rybelsus issues
1% bioavailable, absorbtion varies, take 30 min before food
Tz activates
gip 5x better than sema, glp 5x weaker than sema
tz mods
aib, longer lipid tail, c terminal
glp binding
c term to ecd, n term more selective to tm
reta main benefit
more weight with less m loss
reta effects
lower a1c, blood gluc/lipid, ht, crp (inflamm).
cag (phase 3)
lipidated amylin, 1 a week, amylin + calcineurin receptor
elora (phase 2)
lipidated amylin, 1 a week, only amylin
amylin enhances
wt loss when combo glp1, also ae increase
foundayo
partial ag of glp1 for wt loss, first small molec glp-1 ag
503 b categories
1 = ok, 2 = unsafe 3= no enough info
503 a allowed
fda approved or cat 1
503b allowed
shortage or bulks list